Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome

M. Šabovič,S. Lavre,I. Keber
DOI: https://doi.org/10.1097/01.hjr.0000124213.21584.75
2004-04-01
European Journal of Cardiovascular Prevention & Rehabilitation
Abstract:Objectives We explored the effects of regular consumption of wheat fibre in patients with dysmetabolic cardiovascular syndrome (MCVS). Subjects and methods Forty-two patients with MCVS (mean age 49 ± 8 years) were randomly assigned to a treated group (n = 21) or to a control group (n=21). Patients in the treated group ate 10.5 g of wheat fibre powder per day for the first week, followed by 21 g per day for the next 4 weeks. A standard high-fibre diet was recommended to both groups. Blood pressure, metabolic parameters, fibrinolytic parameters and factor VII activity were measured at entry and after 5 and 9 weeks. Results After completing treatment, patients from both groups lost an average of 1 kg weight. Consumption of wheat fibre resulted in a significant (P<0.05) decrease of systolic and diastolic blood pressure, fasting glucose, glucose 2 h after oral glucose challenge (OGC), total cholesterol, low-density and high-density lipoprotein cholesterol, ranging from 7 to 18%. Furthermore, no significant reductions in fasting insulin, insulin 1 and 2 h after OGC, and glucose 1 h after OGC were found, whereas no differences in fibrinolytic parameters and factor VII activity were observed. Almost all beneficial effects of wheat fibre diminished 4 weeks after its withdrawal. In the non-treated group only a significant decrease of systolic pressure was observed. Conclusions Our results suggest that supplementation of wheat fibre, not just a standard high-fibre diet, may improve cardiovascular risk profile in patients with MCVS, in a manner independent of weight reduction. Eur J Cardiovasc Prevention Rehab 11:144–148 © 2004 The European Society of Cardiology.
What problem does this paper attempt to address?